Approved Hospital Formulary
Suggestions or Corrections? Above and Beyond Nominations Formulary Request
Show Therapeutic Classes
QR Code Add Formweb to your mobile device
Android iOS
Medications not yet evaluated by P&T are considered NON-FORMULARY. Always check 2 unique patient identifiers - NAME and DATE OF BIRTH - at every step!
Please be sure to document all clinical activities daily.
Approved Hospital Formulary
Suggestions or Corrections? Above and Beyond Nominations Formulary Request
Search results for:

isradipine

isradipine
Drug Name Form Strength Formulary Unrestricted Formulary Restricted Non-Formulary Interchange
Dynacirc CAPSULE, ORAL 2.5 mg, 5 mg      
Dynacirc CR TABLET, EXTENDED RELEASE, ORAL 5 mg, 10 mg    
VIEW MORE Dihydropyridines
Comments:

ORDERED FORMULATION

THERAPEUTIC INTERCHANGE

isradipine long-acting (Dynacirc CR)

  • 5 mg extended release oral tablet daily
  • 10 mg extended release oral tablet daily

amLODIPine (Norvasc)

  • 5 mg oral tablet daily
  • 10 mg oral tablet daily

 

Isradipine immediate release capsules are not routinely stocked at HH Main. Isradipine 2.5 mg capsules are available for routine use at HH for Women & Children.

Reviewed: March 23, 2005

Last updated: Sep. 3, 2024






This site is intended for the staff of Huntsville Hospital.
While others may view accessible pages, Huntsville Hospital makes no warranty, express or implied,
as to the use of this information outside of Huntsville Hospital.
Please note than many documents are accessible via the provided link
only when connected to the Huntsville Hospital intranet.

Copyright © 2026 Rpharmy, LLC ­ All Rights Reserved